These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35028473)

  • 1. Towards a 'wide' role for venture capital in OECD countries' industry 4.0.
    Sergi BS; Popkova EG
    Heliyon; 2022 Jan; 8(1):e08700. PubMed ID: 35028473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring and Analysis of Venture Capital and Corporate Fraud Based on Deep Learning.
    Zhang R; Zheng L
    Comput Intell Neurosci; 2022; 2022():4589593. PubMed ID: 35685167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolution Characteristics and Influence Mechanism of Chinese Venture Capital Spatial Agglomeration.
    Yao L; Singleton A; Sun P; Dong G
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33799391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venture funding for science-based African health innovation.
    Masum H; Chakma J; Simiyu K; Ronoh W; Daar AS; Singer PA
    BMC Int Health Hum Rights; 2010 Dec; 10 Suppl 1(Suppl 1):S12. PubMed ID: 21144072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does venture capital Quan Zi affect stock mispricing: Evidence from Chinese listed companies.
    Chen P; Deng L
    PLoS One; 2023; 18(4):e0281255. PubMed ID: 37053247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint venture capital investment for clean technologies and their problems in developing countries.
    Doelle HW
    World J Microbiol Biotechnol; 1996 Sep; 12(5):445-50. PubMed ID: 24415372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How venture capital works.
    Zider B
    Harv Bus Rev; 1998; 76(6):131-9. PubMed ID: 10187243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of public and private funding in the medical device industry.
    Kang HD; Edelman ER; Ku DN
    Expert Rev Med Devices; 2018 Feb; 15(2):91-98. PubMed ID: 29256320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Venture Capital in Enterprise Innovation Under Psychological Capital and Heterogeneity of Entrepreneur Capital.
    Zhang C; Mao D; Wang M
    Front Psychol; 2020; 11():1704. PubMed ID: 32754105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venture Capital Investment in the Life Sciences in Switzerland.
    Hosang M
    Chimia (Aarau); 2014 Dec; 68(12):847-9. PubMed ID: 26508600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venture capital on a shoestring: Bioventures' pioneering life sciences fund in South Africa.
    Masum H; Singer PA
    BMC Int Health Hum Rights; 2010 Dec; 10 Suppl 1(Suppl 1):S8. PubMed ID: 21144079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of platform corporate venture capital vs. traditional corporate venture capital on internet initial public offering underpricing: Evidence from Chinese-listed internet firms.
    Fu F; Chen S
    Front Psychol; 2022; 13():984733. PubMed ID: 36204758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corporate Social Responsibility Amid Social Distancing During the COVID-19 Crisis: BRICS vs. OECD Countries.
    Popkova E; DeLo P; Sergi BS
    Res Int Bus Finance; 2021 Jan; 55():101315. PubMed ID: 34173410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do executives' backgrounds matter to IPO investors? Evidence from the life science industry.
    Chok J; Qian J
    PLoS One; 2013; 8(5):e60911. PubMed ID: 23690920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does venture capital operate in medical innovation?
    Lehoux P; Miller FA; Daudelin G
    BMJ Innov; 2016 Jul; 2(3):111-117. PubMed ID: 27547447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fueling innovation in medical devices (and beyond): venture capital in health care.
    Ackerly DC; Valverde AM; Diener LW; Dossary KL; Schulman KA
    Health Aff (Millwood); 2009; 28(1):w68-75. PubMed ID: 19049999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Internal Connection Analysis of Information Sharing and Investment Performance in the Venture Capital Network Community.
    Feng B; Sun K; Zhong Z; Chen M
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information Sharing and Investment Performance in the Venture Capital Network Community: An Empirical Study of Environmental-Social-Governance Start-Ups.
    Xue C; Dang X; Shi B; Gu J
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.